logo-loader
viewMMJ Group Holdings Ltd

MMJ Group Holdings welcomes MediPharm Labs Corp’s 2019 financial results

Revenue was C$43.4 million, a 38% increase over Q2 2019, as the company expanded its leadership of the Canadian cannabis extraction industry.

MMJ Group Holdings Ltd - MMJ Group Holdings welcomes MediPharm Labs Corp’s 2019 financial results
The company’s balance sheet and financial capacity to support growth remained strong

MMJ Group Holdings Ltd (ASX:MMJ) has welcomed the latest quarterly financial results for its investment MediPharm Labs Corp (TSX:LABS), which posted strong growth in revenue, adjusted EBITDA and net income.

Revenue for the nine months ending September 30, 2019, was C$96.8 million, gross profit was C$32.9 million, adjusted EBITDA C$22.1 million and net income before tax was C$9.2 million.

On-track for $100 million milestone

Chief executive officer and chairman Pat McCutcheon said: “We are on track to surpass the C$100-million milestone in revenue this year, which is a remarkable testament to the tireless efforts of the skilled professionals at MediPharm Labs.

“With the completion of the roll-out of our initial white label products insight, and as the regulated retail distribution system starts to hit stride, we can seize the opportunities that Cannabis 2.0 brings beginning next year.”

On October 10, subsequent to quarter-end, the company closed a credit agreement with top five Canadian Schedule I bank, Scotiabank, for C$38.7 million.

The credit facility was upsized from the previously committed term sheet and comprises a revolving term facility, a non-revolving term facility and a non-revolving delayed draw term facility.

With this larger facility and proceeds from the bought deal equity offering, the company has strengthened its balance sheet and enhanced its financial flexibility.

Quick facts: MMJ Group Holdings Ltd

Price: 0.155 AUD

ASX:MMJ
Market: ASX
Market Cap: $35.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

MMJ Group focuses on strategic vision to be leading cannabis investment company

MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive Investors about its strategic partnership with MMJ operating company Embark Ventures (EBV). The two companies have combined to create the highest quality investments, earnings and share price return for...

on 17/7/19

2 min read